
    
      This is a two-phase, non-randomized, prospective, single arm, multi-center clinical
      investigation. Each subject in Phase 1 and Phase 2 is consented for a period of 5 years. All
      subjects will be assessed for clinical follow-up at the following intervals: Discharge, 1
      month, 3 months, 1 year and annually thereafter until 5 years of follow-up is achieved per
      subject.
    
  